--- title: "Lee's Pharmaceutical Holdings (950) stock and investor profile" url: "https://aibio.space/companies/lee-s-pharmaceutical/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Lee's Pharmaceutical Holdings Limited (HKEX: 950), Hong Kong. The directory classifies it as Pharmaceuticals: Major." --- 950 Lee's Pharmaceutical Holdings Limited HKEX · Hong Kong # Lee's Pharmaceutical Holdings (950) news Lee's Pharmaceutical Holdings Limited is a public biotech or pharmaceutical company listed on HKEX under the ticker 950, recorded under Hong Kong. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Lee's Pharmaceutical Holdings news We have not published a story on Lee's Pharmaceutical Holdings yet. When there is news, it will appear here. ## Lee's Pharmaceutical Holdings at a glance - **Ticker**: 950 - **Listing**: HKEX - **Country**: Hong Kong ### Related companies - [Shenzhen Neptunus Interlong Bio-Technique Co.](https://aibio.space/companies/shenzhen-neptunus-interlong-bio-technique/) HKEX: 8329 - [Beijing Tong Ren Tang Chinese Medicine Co.](https://aibio.space/companies/beijing-tong-ren-tang-chinese-medicine/) HKEX: 3613 - [Regent Pacific Group](https://aibio.space/companies/regent-pacific/) HKEX: 575 - [Extrawell Pharmaceutical Holdings](https://aibio.space/companies/extrawell-pharmaceutical/) HKEX: 858 - [China Biotech Services Holdings](https://aibio.space/companies/china-biotech-services/) HKEX: 8037 - [Pak Fah Yeow International](https://aibio.space/companies/pak-fah-yeow-international/) HKEX: 239 - [Grand Pharmaceutical Group](https://aibio.space/companies/grand-pharmaceutical/) HKEX: 512 - [China Traditional Chinese Medicine Holdings Co.](https://aibio.space/companies/china-traditional-chinese-medicine/) HKEX: 570 ### Also on HKEX - [SSY Group](https://aibio.space/companies/ssy/) 2005 - [JW (Cayman) Therapeutics Co.](https://aibio.space/companies/jw-cayman-therapeutics/) 2126 - [Genfleet Therapeutics (Shanghai)](https://aibio.space/companies/genfleet-therapeutics-shanghai/) 2595 - [PegBio Co.](https://aibio.space/companies/pegbio/) 2565 - [Zai Lab](https://aibio.space/companies/zai-lab/) 9688 - [Innovent Biologics](https://aibio.space/companies/innovent-biologics/) 1801 ## Questions about Lee's Pharmaceutical Holdings What is the ticker symbol of Lee's Pharmaceutical Holdings? Lee's Pharmaceutical Holdings Limited trades under the ticker 950 on HKEX. Where is Lee's Pharmaceutical Holdings listed? Lee's Pharmaceutical Holdings Limited is listed on HKEX. Which country or territory is Lee's Pharmaceutical Holdings listed under? Our directory records Lee's Pharmaceutical Holdings Limited under Hong Kong. What does Lee's Pharmaceutical Holdings do? Our directory classifies Lee's Pharmaceutical Holdings Limited as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline. What is the ISIN of Lee's Pharmaceutical Holdings? The ISIN recorded for Lee's Pharmaceutical Holdings Limited is KYG5438W1116. Does aibio.space cover Lee's Pharmaceutical Holdings? aibio.space lists Lee's Pharmaceutical Holdings Limited among 2,820 public biotech companies and publishes its news here as stories appear. Which companies are similar to Lee's Pharmaceutical Holdings? Companies in our directory listed in the same country and business area as Lee's Pharmaceutical Holdings: Shenzhen Neptunus Interlong Bio-Technique Co., Beijing Tong Ren Tang Chinese Medicine Co., Regent Pacific Group, Extrawell Pharmaceutical Holdings, China Biotech Services Holdings, Pak Fah Yeow International. ## Investor discussion: Lee's Pharmaceutical Holdings Members talk about Lee's Pharmaceutical Holdings (950). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Lee's Pharmaceutical Holdings, newest first. Each line links the filing it comes from. 1. 2026-04-23 Financings Share or debt issue: General Mandates to Repurchase Shares and to Issue New Shares, Re-election of Directors and Notice of Annual General Meeting. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0423/2026042301805.pdf) 2. 2025-12-22 Mergers Transaction under the Listing Rules: Supplemental Announcement in Relation to Discloseable Transaction - Acquisition of Assets. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1222/2025122200580.pdf) 3. 2025-12-08 Mergers Transaction under the Listing Rules: Discloseable Transaction - Acquisition of Assets. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1209/2025120900001.pdf) 4. 2025-04-23 Financings Share or debt issue: General Mandates to Repurchase Shares and to Issue New Shares, Re-election of Directors and Notice of Annual General Meeting. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0423/2025042302155.pdf) ## Press releases Headlines of Lee's Pharmaceutical Holdings's own announcements, newest first. Each opens the full release on the newswire that carried it. 1. 2026-09-22 HKEXnews [Notification Letter and Reply Form to Non-Registered Shareholders - Notice of Publication of Interim Report](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0923/2026092300027.pdf) 2. 2026-09-22 HKEXnews [Notification Letter and Reply Form to Registered Shareholders - Notice of Publication of Interim Report](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0923/2026092300025.pdf) 3. 2026-09-09 HKEXnews [Voluntary Announcement - Business Update on the Licensing Agreement in relation to the Development, Manufacture and Commercialisation of OC-3](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0909/2026090901235.pdf) 4. 2026-08-31 HKEXnews [Interim Dividend for the Six Months Ended 30 June 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0831/2026083101195.pdf) 5. 2026-08-31 HKEXnews [Interim Results for the Six Months Ended 30 June 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0831/2026083101119.pdf) 6. 2026-08-26 HKEXnews [Positive Profit Alert](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0826/2026082601649.pdf) 7. 2026-07-30 HKEXnews [Voluntary Announcement - Investigational New Drug Application in China for Proprietary ADC Project ZK2401 Accepted by NMPA](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0730/2026073001929.pdf) 8. 2026-07-17 HKEXnews [Voluntary Announcement - Entering into Exclusive License-out and Supply Agreement with Ashlins for Interferon Alpha-2B Products outside Greater China](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0717/2026071701459.pdf) 9. 2026-06-16 HKEXnews [Voluntary Announcement - Share Repurchase Program under the Repurchase Mandate](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0616/2026061601620.pdf) 10. 2026-06-01 HKEXnews [Voluntary Announcement - Funding Approved for Synthetic Surfactant Project](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0601/2026060103958.pdf) 11. 2026-05-21 HKEXnews [Annual General Meeting Held on 21 May 2026 - Poll Results](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0521/2026052100969.pdf) 12. 2026-05-11 HKEXnews [Connected Transaction - Investment in Partnership Fund](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0511/2026051101482.pdf) 13. 2026-04-24 HKEXnews [Notification Letter to Non-registered Shareholders and Reply Form](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0424/2026042400653.pdf) 14. 2026-04-24 HKEXnews [Notification Letter to Registered Shareholders and Reply Form](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0424/2026042400649.pdf) 15. 2026-04-23 HKEXnews [Notice of Annual General Meeting](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0423/2026042301861.pdf) 16. 2026-04-23 HKEXnews [General Mandates to Repurchase Shares and to Issue New Shares, Re-election of Directors and Notice of Annual General Meeting](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0423/2026042301805.pdf) 17. 2026-03-30 HKEXnews [Final Dividend for the Year Ended 31 December 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0330/2026033001110.pdf) 18. 2026-03-30 HKEXnews [Announcement of Annual Results for the Year Ended 31 December 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0330/2026033000842.pdf) 19. 2026-03-25 HKEXnews [Voluntary Announcement - Approval of Intrarosa by NMPA](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0325/2026032501779.pdf) 20. 2026-01-27 HKEXnews [Voluntary Announcement - FDA Approval of Supplemental New Drug Application for Adasuve](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0127/2026012701435.pdf) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open HKEX:950 on TradingView](https://www.tradingview.com/symbols/HKEX-950/). ## Listing details Lee's Pharmaceutical Holdings Limited is a public biotech or pharmaceutical company listed on HKEX under the ticker 950, recorded under Hong Kong. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Lee's Pharmaceutical Holdings Limited - **Ticker**: 950 - **Listing**: HKEX - **Country or territory**: Hong Kong - **Business scope**: Pharmaceuticals: Major - **ISIN**: KYG5438W1116 - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/HKEX-950/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/lee-s-pharmaceutical/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Lee's Pharmaceutical Holdings (950) stock and investor profile", 2026-10-31, https://aibio.space/companies/lee-s-pharmaceutical/